Safety of intravenous thrombolysis in embolic stroke by infective endocarditis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Ischemic stroke is a serious neurological complication of infective endocarditis. Intravenous tissue plasminogen activator (t-PA), which has only been approved for treatment of hyperacute stroke, has been excluded as an ischemic stroke treatment due to infective endocarditis according to current expert consensus guidelines. Here, we describe a case of a hyperacute stroke patient treated with intravenous t-PA, who was later diagnosed with infective endocarditis.

Original languageEnglish
Pages (from-to)209-211
Number of pages3
JournalNeurology Asia
Volume18
Issue number2
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Safety of intravenous thrombolysis in embolic stroke by infective endocarditis'. Together they form a unique fingerprint.

  • Cite this